Tanja Nicole Hartmann, MD, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany, comments on the important role of the immune microenvironment in driving drug resistance and in increasing the risk of infections in patients with chronic lymphocytic leukemia (CLL). This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.